Musculoskeletal System Disorders Market Analysis 2020 Global Trends, Size, Opportunities, Sales Revenue, Emerging Technologies and Growth Analysis By 2025

-

The Global Musculoskeletal System Disorders Market is projected to register a CAGR of 5.3% to reach an estimated USD 5.73 billion by 2025. The growth of global musculoskeletal system disorders market is driven by various factors such as an increasing global geriatric population, rising prevalence, and improper posture, and poor fitness levels. However, the high costs of surgery are  expected to curb the growth of the global musculoskeletal system disorders market.
The rising number of cases of work-related musculoskeletal system disorders in developing nations and an increase in the geriatric population in developed nations are driving the growth of the market.
 Musculoskeletal System Disorders Market Key Players:
Some of the key players in the global musculoskeletal system disorders market are
  • AB Science (France)
  • AbGenomics International Inc. (US)
  • Alder BioPharmaceuticals,Inc. (US)
  • Amgen Inc. (US)
  • Lexicon Pharmaceuticals, Inc. (US)
  • LG Chem (South Korea)
  • OrthoTrophix, Inc. (US)
  • Tarsa Therapeutics, Inc. (US)
  • PhytoHealth Corporation (Taiwan)
  • Eisai Co., Ltd (Japan)
  • Astellas Pharma Inc. (Japan) 
  • AstraZeneca (UK)
  • Baxter (US)
  • GlaxoSmithKline PLC (UK).
Musculoskeletal System Disorders Market Regional Analysis
Americas: The largest regional market.
  • North America: The North American market for musculoskeletal system disorders is growing due to an increased prevalence and a growth in healthcare spending in the region.
  • US: About 126.6 million Americans are affected by musculoskeletal disorders and the average cost of treatment for these disorders in the country is USD 332 billion per year. The prevalence of these disorders has increased, and the US government is actively seeking to reduce the financial strain of managing and treating this disorder. Moreover, the prevalence of arthritis in the country is expected to reach 67 million and affect about 25% of the adult population by 2030. The country is also leading the innovation and treatment of musculoskeletal system disorders. These factors are expected to boost the growth of the market in the coming years.
  • Latin America: Steady investments in healthcare infrastructure and improvements in diagnostic abilities are expected to fuel the growth of the market in this region.
Europe: A growing geriatric population and an increase in work-related musculoskeletal system disorder cases are expected to ensure the growth of the market in Europe. The EU has set up numerous occupational safety and health directives to help combat musculoskeletal system disorders.
  • UK: Approximately 9.6 million adults and over 12,000 children in the UK suffer from one of the 200 musculoskeletal system disorders, according to the National Health Service. With over 1 in 4 Britishers afflicted with musculoskeletal system disorders, the country-level market is slated to grow due to increased government spending and support.
  • Germany: There is an increase in the incidence rate of musculoskeletal system disorders among Germany’s young workforce with the greatest number of working days lost were due to these disorders. Moreover, a rise in the number of age-related musculoskeletal system disorder cases is driving the growth of the market in Germany.
Asia-Pacific: The fastest-growing regional market for musculoskeletal system disorders, Asia-Pacific has a growing geriatric population and a very large population base.
  • Japan: Japan has the world’s largest geriatric population, by percentage, and the government is focused on aiding in the management of disorders afflicting the elderly. A large workforce is also contributing to the rise in work-related musculoskeletal system disorder cases, thereby driving the growth of the market.
  • India: The prevalence of rheumatoid arthritis, osteoarthritis, and osteoporosis and high investments in healthcare with an increase in average healthcare spending are driving the growth of the Indian musculoskeletal system disorders market.
  • Middle East & Africa: Limited healthcare infrastructure and diagnostic abilities are restricting the size of the musculoskeletal system disorders market in the region. A low prevalence of geriatric individuals is also restraining the market.
Browse Full Research Report At:  https://www.marketresearchfuture.com/reports/musculoskeletal-system-disorders-market-8232

Related News
Sex Cord Gonadal Stromal Tumor Market

Bariatric Surgery Devices Market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
https://www.marketresearchfuture.com/




Comments

Post a Comment

Popular posts from this blog

Digital Genome Market Share 2020, Size, top companies, status 2027

-
  The research study presented here is an intelligent take on the Digital Genome Market Share by MRFR that explains important aspects such as competition, segmentation, and regional growth in great detail Digital genome is the study of DNA and other genetic information in plants and animals. It is used to discern the nature of chronic diseases and their ability to cure them in the coming years. The global digital genome market report by Market Research Future (MRFR) takes a look at the challenges and opportunities for the industry for the period of 2018 to 2027 (forecast period). The impact of the COVID-19 pandemic and its effects are explored in great detail. Also Read  https://www.abnewswire.com/pressreleases/digital-genome-market-outlook-2020-key-findings-regional-analysis-covid19-effect-key-players-profiles-future-prospects-and-forecast-to-2027_500552.html Digital Genome Market Scope The global  digital genome market  is expected to accrue major revenue...
Read more

Lymphedema Diagnostics Market Size, Growth Analysis and Technology Enhancements Briefing 2020 To 2023

-
  global lymphedema diagnostics market is expected to register a CAGR of ~7.1% during the forecast period of 2019 to 2025 and was valued at USD 22.6 million in 2018. Lymphatic obstruction or lymphedema is a long-term condition where the excess fluid forms in the body tissue and causes swelling commonly called edema. It develops due to the damaged lymphatic system. Sometimes it also develops after the treatment of breast cancer. Avail a Free sample@ https://www.marketresearchfuture.com/sample_request/8761 Segmentation The global lymphedema diagnostics market has been segmented based on type, technology, disease type, and end user. The market, based on type, has been divided into primary and secondary. The secondary lymphedema is likely to hold maximum market share in the global lymphedema diagnostics market owing to the large population related to the secondary lymphedema presence across the globe. The global lymphedema diagnostics market based on technology has been segregated int...
Read more

Parry-Romberg Syndrome Market 2019 size, share, Analysis, Growth, Guidelines, Overview, Upcoming Trends and Forecast to 2023

-
Image
According to the National Organization for Rare Disorder, Parry-Romberg syndrome is a rare and acquired disorder, which slowly shrink the skin and tissues of half of the face in most of the cases. In rare cases, both sides of the face are affected. In some cases, it may also affect the limbs usually on the same side of the body. The global Parry-Romberg syndrome market is expected grow at a steady CAGR of 7.8% during the forecasted period. The global Parry-Romberg syndrome market is majorly driven by the increasing skin diseases patient population, increasing prevalence neurological disorders, and rapidly increasing demand for better diagnosis & treatment methods. Key players of the market: ·          DePuy Synthes (U.S.) ·          Johnson & Johnson Services, Inc. (US) ·          Medtronic (Ireland, ·     ...
Read more